ResApp revamps clinical trial of smartphone app to diagnose respiratory disease
CEO Tony Keating shared some of the lessons learned from the first trial in a Skype interview from Sydney, Australia.
CEO Tony Keating shared some of the lessons learned from the first trial in a Skype interview from Sydney, Australia.
ResApp has developed a smartphone app that uses audio samples of a patient's cough to diagnose acute respiratory diseases. A U.S. pediatric study will assess how the app stacks up against respiratory tests conducted by hospitals to diagnose patients.
For illnesses, such as pneumonia, each person creates a unique sound signature when they cough. Based on four to five coughs, signal-processing algorithms in this app can detect those patterns, identifying both the type and severity of an ailment.